Features
Topics
Discover

Unlock the potential of your career in the Pharma industry with our online courses and qualifications.

Career Path

Pick a career path, follow its guided course roadmap, and secure industry-verified credentials in a few months.

Courses

Earn career credentials from industry leaders that demonstrate your expertise.

Black Friday Sale: 50% OFF Annual Subscription – Nov 12 to Dec 1!

Good Manufacturing Practices Requirements in 2025

Good Manufacturing Practices (GMP) Requirements protect patients and support safe, effective medicines. Good Manufacturing Practices define how manufacturers design facilities, train people, control processes, and release products. Therefore, GMP standards sit at the heart of every serious pharmaceutical quality system. 

Today, regulators treat good manufacturing practices requirements as legal obligations, not suggestions. More than 100 countries now build their national GMP rules on the WHO GMP guide. Meanwhile, the FDA increased warning letters per 100 inspections by around 43% between 2019 and 2023, which shows tougher enforcement of GMP compliance requirements. 

However, GMP requirements do not look identical worldwide. WHO issues global guidance that many low- and middle-income countries adopt or adapt to. The US FDA sets current GMP (CGMP) rules in federal regulations for drugs and biologics. The EU defines GMP standards in EudraLex Volume 4, plus detailed annexes for sterile products and special technologies. As a result, manufacturers must align one internal GMP checklist with several overlapping rule sets. 

Core Good Manufacturing Practices Requirements Overview in 2025

At a high level, good manufacturing practices requirements always cover the same core pillars. Regulators want companies to build strong GMP quality systems that prevent defects rather than chase them later. Therefore, every site needs robust governance, qualified people, controlled facilities, and reliable documentation. 

Across WHO, FDA, and EU frameworks, nine themes appear again: 

  1. Quality Management System and senior leadership oversight. 
  2. Personnel Qualifications, GMP training, and clear responsibilities. 
  3. Facility and Equipment Design that supports clean, controlled operations. 
  4. Production and Process Control, including change control and deviation handling. 
  5. GMP Documentation and record-keeping that proves “what happened, when, and by whom.” 
  6. GMP Validation and Qualification for processes, equipment, and systems. 
  7. Quality Control and testing before batch release. 
  8. Packaging and Labeling controls to prevent mix-ups and errors. 
  9. Distribution and Supply Chain Controls, often aligned with WHO good distribution practices.  

Moreover, regulators expect regular internal GMP audits, strong data integrity, and transparent responses to findings. In 2023, FDA issued 94 warning letters to drug manufacturing sites over quality problems, many linked to basic GMP documentation and process control gaps. 

List of GMP Requirements

The sections below group GMP requirements into nine mandatory areas. Each area supports the others, so strong GMP compliance requirements depend on balance and consistency across the full system. 

good manufacturing practices requirements

1. Quality Management System

A strong Quality Management System (QMS) sits at the center of GMP. It links strategy, operations, and continuous improvement into one clear structure. Therefore, leaders use the QMS to guide every decision that affects product quality.

2. Personnel & Training Requirements

GMP starts with competent people who understand their roles. Every employee needs the right skills, attitude, and training before handling products or data. In addition, managers must lead by example and reinforce good practices daily. 

3. Facility & Equipment Requirements

Facilities and equipment must support clean, controlled, and efficient manufacturing. The layout should reduce contamination risks and keep flows simple. At the same time, robust utilities and maintenance plans keep systems reliable.

4. Production & Process Control Requirements

Production and process control requirements keep each batch within approved limits. They translate development knowledge into practical shop-floor instructions. As a result, operators follow a clear roadmap from raw material to finished product. 

5. Documentation & Record-Keeping Requirements

Good documentation proves that the right actions happened at the right time. It also allows teams and inspectors to reconstruct each batch history. Therefore, companies must treat documents and records as core quality tools, not bureaucracy. 

6. Validation & Qualification Requirements

Validation and qualification show that facilities, utilities, equipment, and processes are performed as intended. They reduce uncertainty and support confident batch release. In addition, they give regulators concrete evidence that systems stay under control. 

7. Quality Control & Testing Requirements

Quality Control (QC) checks whether materials and products meet specifications. The QC lab acts as an independent gatekeeper for batch release. However, QC does not work alone; it links closely with production and QA. 

8. Packaging & Labeling Requirements

Packaging and labeling protect the product and the patient. Errors here can cause serious safety incidents. Consequently, companies must design packaging operations that minimize mix-ups and wrong information. 

9. Distribution & Supply Chain Requirements

GMP responsibilities continue after batch release. The distribution and supply chain network must preserve product quality until it reaches patients. Therefore, manufacturers need strong links to GDP principles and reliable partners. 

WHO vs FDA vs EU GMP Requirements

While WHO, FDA, and EU frameworks share common principles, they differ in legal status, structure, and emphasis. The table below summarizes key differences in GMP Requirements: 

Aspect WHO GMP Requirements FDA GMP Requirements EU GMP Requirements (EudraLex)

Main scope

Global guidance for member states
US drugs, biologics, some devices
EU/EEA human and veterinary medicines

Legal force

Non-binding model, adopted into national law
Binding federal regulations (21 CFR 210/211, etc.)
Binding Directives / Regulations plus guidelines

Guideline structure 

WHO Technical Reports and GMP manuals
Regulations plus guidance documents
EudraLex Vol. 4: Part I, Part II, Annexes

Focus areas

Foundational GMP standards and capacity building
Detailed expectations and strong enforcement
Risk-based control, Annex-driven specific topics

Inspection model 

Prequalification, support to national authorities
FDA inspections worldwide
National authorities plus EMA coordination

Recent trends 

Support for LMIC systems and prequalification schemes
Rising share of CGMP-related warning letters
Revised Annex 1 for sterile products and new rules

WHO guidelines often serve as a reference for national regulators that build local GMP standards. FDA rules sit directly in US law, and FDA inspections worldwide enforce FDA GMP requirements. The EU relies on EudraLex Volume 4 and its annexes, including a recently updated Annex 1 that tightens controls for sterile manufacturing.  

Because of this, global manufacturers usually design one integrated GMP quality system. Then they map that system against WHO GMP requirements, FDA expectations, and EU rules. A structured GMP checklist helps teams confirm coverage across all three regions. 

good manufacturing practices requirements

Final Words

Good Manufacturing Practices Requirements keep medicines safe, effective, and consistent from batch to batch. This article outlined the nine core GMP pillars: quality management, people, facilities, production control, documentation, validation, QC, packaging, and distribution. Together, these elements form a living GMP quality system that supports everyday operations and long-term compliance. 

Moreover, global regulators continue to raise the bar. WHO updates its guidance, FDA tracks data from inspections and warning letters, and the EU refines annexes like Annex 1. Therefore, manufacturers need ongoing training, internal GMP audits, and regular gap assessments to keep pace with changing expectations. 

If professionals want to deepen their expertise, they can explore pharma courses that focus on GMP compliance requirements, GMP audits, and GMP documentation best practices. Strong knowledge of GMP standards supports better decisions, safer products, and a more resilient pharma career. 

FAQ:

What are the main GMP requirements?

Good Manufacturing Practices Requirements cover nine key areas: quality management, personnel, facilities, production control, documentation, validation, QC testing, packaging, and distribution. Moreover, regulators expect companies to link these areas into one strong GMP quality system. As a result, manufacturers reduce risk and protect patients. 

How do WHO GMP requirements differ from FDA and EU GMP standards?

WHO GMP requirements offer global guidance that many countries use as a model. However, FDA GMP requirements sit directly in US law and include detailed CGMP rules and strict enforcement. EU GMP standards follow EudraLex Volume 4 and focus strongly on risk management and annexes like sterile manufacturing. Therefore, global companies map one system to all three.

What documentation do companies need for GMP compliance requirements?

Firms need clear SOPs, batch records, logbooks, cleaning records, validation reports, and training files. Moreover, they must apply data integrity principles to all GMP documentation, whether on paper or in electronic systems. Therefore, inspectors can trace who did each action, when, and why. 

Why does GMP validation matter to manufacturers?

GMP validation shows that processes, equipment, and systems perform as expected over time. In addition, it supports consistent quality and reliable batch release decisions. Therefore, regulators treat validation data as core evidence of compliance with good manufacturing practices requirements.

References:

Picture of Stephanie Männicke

Stephanie Männicke

Digital Marketing Especialist at Zamann Pharma Support, brings 8 years of experience in Corporate and Digital Communication. Specializing in Digital Marketing and Content Creation, Stephanie is currently focused on creating strategic content for Pharmuni's networks, especially content on topics such as recruitment, onboarding and employer branding. Outside of work, Stephanie is a mum, a crocheter and a movie fan. An avid reader and in search of expanding her knowledge, Stephanie is always looking for ways to innovate communication in the digital environment and connect people in a genuine way.

Share